2 published verifications about Type 1 Diabetes Type 1 Diabetes ×
“Living Cell Technologies conducted clinical trials in New Zealand in which islet cells from Auckland Island pigs were transplanted into eight patients with type 1 diabetes.”
The core description is accurate, but the patient count is incomplete. Reliable sources confirm that Living Cell Technologies conducted New Zealand trials transplanting Auckland Island pig islet cells into people with type 1 diabetes. However, the strongest later evidence reports 14 patients treated overall, so “eight patients” appears to describe only an early cohort, not the full New Zealand trial program.
“Individuals with Type 1 diabetes have nearly three times the risk of developing dementia compared to individuals without Type 1 diabetes.”
Type 1 diabetes is associated with elevated dementia risk, but "nearly three times" overstates the typical finding. The most comprehensive quantitative synthesis — a 2025 systematic review and meta-analysis — reports a pooled hazard ratio of approximately 1.50 (a 50% increase), while a large nationwide cohort study found roughly double the risk. The ~2.8× figure comes from one specific recent study and media reports echoing it, not from the broader evidence base. The claim cherry-picks the highest estimate rather than reflecting the range of peer-reviewed findings.